Introduction
The epithelial-mesenchymal transition (EMT) is a developmental process, which has gained much attention because of its potential role in converting benign tumors into invasive and metastatic counterparts. [1] [2] [3] [4] During EMT the expression of junction proteins and other epithelial characteristics are lost, which results in tumor cells losing their capacity to interact with each other. 5 In parallel, EMT cells gain increased migratory capacity due to increased expression of mesenchymal proteins like vimentin and alpha-smooth muscle actin (α-SMA). Thus, tumor cells undergoing EMT acquire the capacity to migrate and invade the surrounding stroma and subsequently spread via blood and lymphatic vessels to distant sites. 5 Recently, it was discovered that cells undergoing EMT acquire stem cell-like characteristics showing a link between EMT and stem cell pathways. 6, 7 This suggests that EMT might contribute to the population of cancer stem cells that have been identified in breast tumors and other types of human cancer. 8, 9 Thus, EMT might provide tumor cells with the capacity to both invade the surrounding tissue and to repopulate distant sites as metastases. So, what drives EMT in cancer?
Transforming growth factor-beta (TGF-β) is a major inducer of EMT during development and is overexpressed in many types of human cancer suggesting a role for TGF-β as an inducer of EMT in tumors. 10, 11 Paradoxically, TGF-β also has antiproliferative tumor suppressive effects and inactivating mutations or epigenetic silencing of various components of the TGF-β signaling pathway predisposes to cancer and inflammation Tumor cells undergoing the epithelial-mesenchymal transition (eMT) acquire the capacity to migrate, invade the stroma and metastasize. eMT cells also acquire stem cell characteristics suggesting crosstalk between eMT and pathways involved in promoting cellular stemness (stem cell pathways) and that eMT may contribute to the generation of cancer stem cells. indeed, transforming growth factor-beta (TGF-β), a major inducer of eMT, cooperates with stem cell pathways like wnt, ras, Hedgehog and Notch to induce eMT. A molecular basis for this cooperative signaling is indicated by recent data showing that many eMT associated transcription factors like Snail1, Zeb1/2, Twist, β-catenin, Lef/TCF, Foxc2 and AP-1 interact with Smads and form eMT promoting Smad complexes (ePSC) engaged in either repressing epithelial genes or activating mesenchymal genes. Thus, formation and activation of ePSC represents a point of convergence between eMT and stem cell pathways. Here, we review our current understanding of the mechanisms involved in the transcriptional crosstalk between TGF-β and stem cell pathways and discuss how a fundament for the activation of these mechanisms may lead to the induction of eMT in tumors.
Smads have low affinity for DNA and need to interact with cofactors to achieve target specificity. Depending on cofactors available, Smad complexes may either promote activation or repression of target genes. Recently, it has been discovered that several EMT-promoting transcription factors including Snail, Zeb1, Zeb2, AP-1, LEF1/TCF and Sp1 can act as cofactors for Smads. Interaction of these transcription factors with Smads results in the formation of EMT promoting Smad complexes (EPSC). The expression and activation of these transcription factors is co-regulated by TGF-β and stem cell pathways suggesting that cells under the influence of signaling from stem cell pathways are particularly sensitive to TGF-β induced EMT.
The aim of this review is to highlight recent findings that have led to an increased understanding of the transcriptional crosstalk involved in the cooperative induction of EMT by TGF-β, Wnt and Ras signaling. In particular, we have focused on the emerging concept that many transcription factors associated with EMT interact with Smads and form EPSC that drive the EMT by both repressing epithelial genes and by activating mesenchymal genes. Although other pathways, such as Hedgehog and Notch also provide important links between EMT and the regulation of cellular stemness we have chosen to focus on some principal findings rather than to cover the entire field of EMT research, which is thoroughly discussed in several recent excellent reviews. 2, 3 In perspectives we discuss how the cues for the induction of EMT may be created at tumor invasive niches where TGF-β and stem cell pathways are simultaneously activated.
EMT in Cancer Cell Invasion and Metastasis
Epithelial barrier function and integrity is dependent on the formation of intercellular junctions. E-cadherin constitutes the major transmembrane component of adherens junctions and is essential for epithelial cell-cell interactions. 16 Loss of E-cadherin is frequently detected during carcinoma progression and is used by pathologists as a marker for tumor cell invasion. 17 Conversely, experiments using transgenic animals have demonstrated a role of E-cadherin in the prevention of migration and invasion. 18 Loss of E-cadherin is a typical feature of EMT. 19 Besides E-cadherin, other epithelial genes, such as the tight junction proteins claudin, occludin and coxsackieand adenovirus receptor (CAR) and cytokeratins are repressed, whereas the expression of mesenchymal genes, such as Snail1, vimentin and fibronectin is upregulated. 5 EMT is triggered not only during tumor progression but also in other pathological conditions characterized by inflammation and fibrosis. 2, 20 It has been proposed that around 30% of accumulating fibroblasts during experimental kidney fibrosis in mice originate from epithelial cells that have undergone EMT. 21 EMT, and loss of E-cadherin, is associated with increased tumor cell invasion and metastasis. 17, 18, 22, 23 Expression of other EMT markers is also associated with invasion. 20 EMT has also been linked to other features of cancer. For instance, cells undergoing EMT become resistant to apoptosis when challenged with ionizing radiation, genotoxic drugs or indicating that the capacity of TGF-β to induce EMT is contextual. 12, 13 Concordantly, not all cultured epithelial cells undergo EMT in response to TGF-β. In contrast, few cultured cell lines, including Namru mammary gland epithelial cells (NMuMG) are highly sensitive to TGF-β induced EMT. 14, 15 Accordingly, NMuMG cells are frequently used as a model system to study mechanisms of TGF-β induced EMT (Fig. 1) .
TGF-β cooperates with Wnt, Hedgehog, Notch and Ras signaling pathways to induce complete EMT. Interestingly, these are pathways involved in the induction and maintenance of stem cell niches. Thus, co-activation of stem cell pathways may shift the cellular response to TGF-β towards EMT. An explanation for this may lie in the subtle design of the TGF-β signaling pathway.
TGF-β binding to its receptors leads to activation of Smads, intracellular transcription factors and transducers of TGF-β signaling. Smad complexes are translocated into the nucleus where they regulate transcription of TGF-β target genes. However, an important role in carcinoma progression into an invasive state. 46, 47, 50 However, the role of TGF-β in cancer is complex. At early stages of tumor growth, TGF-β seems to act as a tumor suppressor by inducing growth arrest and apoptosis. During tumor progression the growth inhibitory response to TGF-β is decreased while the EMT response is retained or even increased. 10, 50 TGF-β binding results in complex formation of type I and type II receptors, which subsequently leads to phosphorylation and activation of downstream effectors of the Smad family. 51, 52 The receptor-activated Smad2 and Smad3 (R-Smads) become phosphorylated, associate with cytoplasmic Smad4 (co-Smad) and translocate to the nucleus where Smad complexes regulate transcription of target genes through interaction with specific binding motifs in gene regulatory regions. 12 However, Smad transcription factors have low affinity for DNA and need to interact with transcriptional cofactors to achieve high affinity and selectivity for target genes. This delicate design of the Smad signaling pathway allows cells to read TGF-β signals differently: therefore, the outcome of the TGF-β response in a given cell type depends on the array of Smad cofactors accessible and active at the time of TGF-β exposure. 12 Smad signaling is essential for TGF-β-induced EMT.
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Smad3/Smad4 enhances the induction of EMT by activated TGF-β receptor I while dominant negative Smad3 blocks TGF-β-induced EMT in NMuMG cells. 53, 54 Renal tubular epithelial cells deficient in Smad3 fail to undergo EMT and keratinocytes derived from Smad3 -/-mice show reduced migration in response to TGF-β. 55, 56 Similarly to Smad3, Smad4 is essential for TGF-β-induced EMT. Knockdown of Smad4 through RNA-interference or dominant negative approaches results in preserved E-cadherin expression upon TGF-β treatment, 54,57-60 suppression of fibrotic type I collagen synthesis in vitro, 58 and decreased bone metastasis in vivo. 57 Furthermore, Smad4 promotes tumor cell invasion in advanced pancreatic tumors. 61 Thus, Smad3 and Smad4 transcription factors are important for TGF-β induced EMT.
Wnt signaling. Wnt signaling regulates stem-cell renewal and is implicated in the induction of EMT in cancer. Aberrant Wnt signaling through overexpression of Wnt ligands or silencing of endogenous inhibitors of Wnt signaling has been reported in numerous types of human cancer including colon, breast, melanoma and prostata carcinomas and has been linked to EMT. [62] [63] [64] [65] [66] [67] Wnt signaling is essential to maintain tumor cells in a dedifferentiated state and a Wnt antagonist [i.e., Dickkopf-related protein 1(DKK1)] reduces tumor size and metastasis. Loss of the Wnt antagonist secreted frizzled-related protein 1 (SFRP1) is common in human breast cancer. 68 Silencing of SFRP1 results in the induction of Wnt signaling, EMT and stem cell-like properties including the CD44 high /CD24 low signature. 63 CD24 is a direct target of Wnt signaling and Six1, a homeodomain protein, which regulates the population of progenitor cells during development, induces EMT, stem-like traits and Wnt signaling in mammary epithelial cells. 35, 64 Activation of canonical Wnt signaling is initiated by binding of Wnt ligands (typically Wnt1 or Wnt3a) to cell surface receptors composed by Frizzled (Fzd) and the LDL receptor-related proteins LRP5 or LRP6. Signaling from the receptor complex via Dishevelled (Dvl) and Axin results in stabilization and nuclear pro-apoptotic cytokines. [24] [25] [26] Breast epithelial cells undergoing EMT display a self-renewal capacity suggesting that these cells acquire properties of tumor-initiating cells. 6, 7 Moreover, EMT in melanoma cells promotes immunosuppression through the expression of thrombospondin 1 (TSP-1).
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EMT and Cancer Stem Cells
The idea that disseminating cancer stem cells represent the origin of metastasis was proposed in 2005 suggesting that EMT might provide cells with both migratory and stem cell properties. 28, 29 Three years later Weinberg and colleagues provided experimental evidence linking EMT to cancer stem cells. They showed that cells induced to undergo EMT (by Twist/Snail/TGF-β) acquired a CD44 high /CD24 low signature, similar to a small sub-population of breast cancer stem cells that previously had been isolated and identified to have a unique ability to form tumors in xenograft models. 6, 8 Moreover, EMT cells could form mammospheres, differentiate into cells of different lineages (i.e., myoepithelial or luminal epithelial cells) and reconstitute a heterogeneous tumor, thus confining many properties of stem cells. 6 Another study utilized a different model, where EMT was induced by activation of the Ras-MAPK pathway. These cells also displayed stem-like properties and a CD44 low /CD24 high signature. 7 Further studies have reinforced a link between EMT and cancer stem cells. 30 In one report, circulating tumor cells from breast cancer patients that were classified as responders and nonresponders to chemotherapy were isolated. 31 Non responders displayed both EMT and cancer stem cell signatures and expressed aldehyde dehydrogenase isoform 1 (ALDH1), a stem cell marker in breast, colon, lung and head and neck carcinomas. 31, 32 In another study metaplastic breast cancer, a rare and aggressive form of human breast cancer, was associated with an EMT and cancer stem cell gene signature. 33 Furthermore, silencing of p21 (CIP1) increases the rate of experimental Ha-Ras/c-Myc-induced carcinogenesis and the expression of both EMT and embryonic stem cell markers including SRY sex determining region Y-box 2 (Sox2), Oct4 and kruppel-like factor 4 (KLF4). 34 Snail1 and Snail2 (Slug), transcriptional repressors and inducers of EMT, were shown to mediate radio-and chemo-resistance to ovarian cancer cells by inducing expression of stem-like promoting genes, such as Nanog, KLF4 and T cell factor 4 (TCF4) and by suppressing p53-mediated apoptosis. 35 
Signaling Pathways in EMT
While TGF-β treatment alone is sufficient to induce EMT in some cultured epithelial cells other cells are resistant or moderately sensitive to TGF-β induced EMT.
14 It has been shown that TGF-β needs to cooperate with other signaling pathways, such as Wnt. 36, 37 Hedgehog, 38 oncogenic Ras/receptor tyrosine kinases, [39] [40] [41] [42] and Notch 43, 44 to induce complete EMT. [45] [46] [47] Notably, these are all pathways linked to stem cell renewal/ proliferation. 48, 49 TGF-β/SMAD signaling. TGF-β is essential for the induction of EMT during various stages of embryogenesis and plays expression in cells with moderate levels of Ras signaling. 90 Raf and TGF-t cooperate to repress E-cadherin both at transcriptional and posttranslational levels. 91 RSK is a downstream kinase target of the Ras-ERK-pathway and was recently discovered to be an important mediator of epithelial cell motility and invasion. 92 An unexpected and conceptually intriguing study showed that expression of the transcription/translation regulatory protein Y-box binding protein-1 (YB-1) resulted in EMT. 93 The induction of EMT was Ras-dependent and the mechanism by which YB-1 acted involved cap-independent translation of messenger RNAs encoding a network of EMT-inducing transcription factors including Snail1 and Twist. Furthermore, YB-1 expression was detected in invasive and aggressive human breast tissues. H-Ras signaling has been shown to modulate global and genespecific histone modification patterns during EMT in colorectal carcinoma cells. 94 These studies indicate that mechanisms involving posttranslational and chromatin modifications, which are known to be important for tumor progression, also play roles in EMT. 95, 96 Transcriptional Regulation of EMT EMT involves both transcriptional inactivation of epithelial genes and activation of mesenchymal genes. A number of transcription factors have been identified to play roles in these processes. Some of them have the capacity to induce a whole EMT program in cells while others are more specifically involved in the regulation of a distinct subset of epithelial/mesenchymal target genes. Based on their mechanism of action we have chosen to divide EMT promoting transcription factors into two groups: (1) repressors of epithelial genes and (2) activators of mesenchymal genes (Fig. 2) . Below, we discuss the mechanism of action of these transcription factors and how TGF-β, Wnt and Ras pathways cooperatively regulate their activities.
Transcriptional repression of epithelial genes-role of Snail, Zeb and bHLH transcription factors. Loss of E-cadherin expression is a hallmark of EMT. Early studies suggested that the repression of E-cadherin during EMT was a consequence of the action of a specific inhibitor acting through its association with E-box sequences containing a core 5'-CACCTG-3' motif within the E-cadherin promoter. 97, 98 Subsequently, Snail1 was identified as a transcription factor capable of repressing E-cadherin through direct binding to these E-boxes. 99, 100 Additional transcription factors including Snail2 (Slug), 101 the basic helix-loop-helix protein E47/TCF3, 102 and the two zinc-finger-E-box binding homeobox factors Zeb1 (dEF1 or Tcf8) and Zeb2 (SIP1) 103, 104 have been identified as repressors of E-cadherin transcription through interaction with the same E-boxes.
Snail1 overexpression is sufficient to induce EMT and the expression of other repressors suggesting that Snail1 may act as an early switch to promote an EMT program in cells. 19, 105 This is supported by data showing that Snail1 is rapidly and transiently upregulated at the transcriptional level during TGF-β induced EMT in NMuMG cells. 106 Upregulation of Snail in response to TGF-β is mediated through transcriptional cooperation between Smads and HMGA2. 88 Growth factor mediated activation of Ras translocation of β-catenin through inhibition of the destruction complex, consisting of Axin, adenomatous polyposis coli (APC) and glycogen synthase kinase-3beta (GSK-3β), which in the absence of Wnt signaling promotes phosphorylation and proteolytic degradation of β-catenin. 69 Activation of Wnt signaling leads to inhibition of GSK-3β and stabilization and nuclear translocation of β-catenin, which forms a complex with TCF/ lymphoid enhancer factor (LEF) transcription factors and regulates the transcription of Wnt target genes. 70 Other Wnt proteins, such as Wnt5a, act through non-canonical pathways such as the Wnt/planar-cell-polarity (PCP), the Wnt/Ca 2+ and the receptor tyrosine kinase-like orphan receptor 2 (ROR2) pathways. 71 Wnt proteins promote stem cell self-renewal and govern many aspects of adult tissue homeostasis through the control of β-catenin transcription and activity. 72 Constitutively activated β-catenin signaling predisposes to tumorigenesis and leads to excessive stem cell renewal/proliferation. 73, 74 Nuclear β-catenin is confined to the invasive front in colorectal cancer suggesting that it can be used as a marker of EMT, in vivo. 75 However, loss of E-cadherin in tumors does not imply nuclear localization of β-catenin and activation of Wnt responsive genes per se since these events also require inhibition of the destruction complex. 76 GSK-3β is a nodal protein, which regulates stability and activity of not only β-catenin but also other EMT related transcription factors, such as Snail1. 77 GSK-3β mediated phosphorylation of Snail promotes its nuclear export and degradation. Interestingly, the target phosphorylation site for GSK-3β is conserved in β-catenin and Snail1 proteins. GSK-3β repression has also been reported to promote Snail transcription through the activation of NFκB.
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Ras signaling. Ras activation is a key event following receptor tyrosine kinase (RTK) stimulation by growth factors, such as EGF and FGF, and leads to the activation of PI3Kinase and Raf/ERK/MAPkinase pathways that regulate cell migration, proliferation, survival and cell cycle processes. 79 Ras cooperates with TGF-β to induce EMT but the mechanisms of cooperation between these pathways are not well understood. 45, [80] [81] [82] Ras signaling has been shown to alleviate the anti-proliferative effects of TGF-β by reducing actin fibers and cell-matrix adhesion via a mechanism involving tropomysin. 80 Similarly, Ras signaling was shown to modulate Smad3 levels and thereby affect the TGF-β response in mammary epithelial cells. 83 Colon cancer cells transformed with H-Ras, but not with K-Ras, express an EMT signature suggesting that Ras family members have different capacity to induce EMT. 84 M-ras has also been identified as an inducer of EMT in mammary epithelial cells. 85 A transcriptional target of Ras signaling is the high-mobility group A protein 2 (HMGA2), 86 which is induced by TGF-β and directly regulates the expression of the EMT promoting transcription factors Snail1 and Twist. 87, 88 Ras signaling is required for the induction of EMT by the secreted interleukin-like EMT inducer (ILEI). 89 Different elements have been associated with Ras modification of the epithelial phenotype: whereas MAPK signaling is required for the acquisition of the EMT phenotype PI3Kinase signaling has been implicated in the scattering phenotype. Inhibition of the ERK-MAPK pathway restores E-cadherin transcriptional complex in colon cancer cells. 112, 113 Thus, similar to Snail1, Snail2 is co-regulated by TGF-β and Wnt pathways.
Zeb1 and Zeb2 are upregulated by TGF-β and were shown to be essential for the repression of E-cadherin during TGF-β-induced EMT in NMuMG cells. 114 However, the precise role of Zeb proteins in TGF-β signaling is not clear. It has been proposed that Zeb1 and Zeb2 exert opposing effects on TGF-β signaling; while Zeb1 would enhance Smad effects on the TGF-β targets, Zeb2 would repress expression of these genes. 115 These effects were suggested to be a consequence of the recruitment of transcriptional activators (p300 and p300/CBP-associated factor cooperates with TGF-β to induce Snail1 expression. 107, 108 In addition, Snail1 activity is regulated at the post-translational level by GSK-3β, a major Wnt signaling target, which phospohorylates Snail1 and thereby promotes its nuclear export and degradation. 77 Wnt signaling also directly induces the expression of Snail1. 109, 110 Thus, there is evidence that TGF-β, Wnt and Ras cooperate to activate and stabilize Snail1 during EMT.
Snail2 is also regulated by TGF-β and is a downstream mediator of TGF-β1-induced matrix metalloproteinase-9 (MMP-9) expression and invasion of oral cancer cells. 111 In addition, Snail2 has been reported to be a direct target of the β-catenin Figure 2 . Transcriptional crosstalk between TGF-β, wnt and ras signaling pathways in eMT. TGF-β binding to its receptor results in phosphorylation and nuclear translocation of Smad transcription factors, which achieve target gene specificity through interaction with transcriptional cofactors. eMT promoting transcription factors including epithelial repressors (epr), such as Snail, Zeb and Twist, and mesenchymal activators (MeA), such as β-catenin (β-cat), AP-1, Foxc2, TCF and Sp1 interact with Smads, which results in the formation of eMT promoting Smad complexes (ePSC). These complexes drive eMT by repressing epithelial genes, such as e-cadherin, or activating mesenchymal genes, such as vimentin. Signals from wnt and/or ras pathways promote activation of Snail, Zeb, β-catenin and other eMT promoting transcription factors that can partner and form ePSC with Smads. Thus, the formation of ePSC represents a point of convergence between TGF-β, wnt and ras pathways. GSK-3β is a nodal protein, which negatively regulates stability of Snail and β-catenin. Activation of wnt and ras/Pi3K/AKT pathways leads to inhibition of GSK-3β and thereby stabilization of Snail and β-catenin. TGF-β and ras/raf/erK pathways also regulate eMT promoting transcription factors.
stimulation of AP-1 substituted for EGF in the induction of EMT by TGF-β1. 134 Recently, it was reported that AP-1 is involved in the induction of Snail1 and Snail2 expression in MAP kinase kinase (MEK1)-induced EMT in intestinal epithelial cells 135 and in the induction of vimentin in Ha-Ras-induced EMT in colon cancer cells. 135, 136 β-catenin is activated through Wnt signaling and interacts with TCF4/LEF transcription factors to induce the expression of EMT related genes including Snail2, fibronectin and vimentin. 112, 137, 138 β-catenin also interacts with Snail and other EMTrelated factors, such as Hif-1α, Forkhead box 3a (Foxo3a), Foxo4 and estrogen receptor alpha (ERα) suggesting that β-catenin complexes play important roles in EMT. [139] [140] [141] [142] Overexpression of E-cadherin inhibits β-catenin-dependent transcription of fibronectin and LEF1, 143 that can induce EMT in colon carcinoma cells. 144 NFκB overexpression is sufficient to induce EMT in mammary epithelial cells, upregulate the expression of Snail1 and other mesenchymal specific genes. 145 NFκB is also involved in the induction of EMT by other signaling pathways, such as PI3K/ Akt. 146 Similar to β-catenin transcriptional activity, NFκB activity is repressed by E-cadherin. 143, 147 Finally, Sp1 is required for TGF-β induced expression of vimentin and the induction of EMT in pancreatic cancer cells.
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Sp1 seems also to be involved in the induction of MMP-9 in Snail expressing MDCK cells.
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EMT Promoting Smad Complexes
As previously mentioned, Smads achieve target gene specificity through interaction with transcriptional cofactors. Recent data show that many EMT promoting transcription factors including Snail1, Zeb1/2, Twist, β-catenin and AP-1 have the capacity to act as Smad cofactors (Fig. 2) . Their interaction with Smads results in the formation of EPSC, which engage in either the repression of epithelial genes and the activation of mesenchymal genes ( Table 1) . The accessibility and stability of Smad cofactors may represent a rate-limiting step, which determines whether EPSC will form and drive the TGF-β response towards an EMT. Increased expression and stability of these cofactors via activation of Wnt and/or Ras signaling pathways may sensitize cells to TGF-β induced EMT.
EMT promoting Smad repressor complexes. Snail1 interacts with Smad3/4 and forms a Snail1-Smad3/4 complex, which is recruited to adjacent E-boxes and Smad-binding elements (SBE) within CAR and E-cadherin promoters during EMT in breast epithelial cells. 60 Snail1-Smad3/4 complexes repress CAR and occludin promoters during TGF-β induced EMT in NMuMG cells, whereas repression of E-cadherin seems to be more dependent on Zeb1 and Zeb2 than Snail1. 60, 114 Zeb2 was initially characterized as a Smad-binding protein. 150 More recently, Zeb1 was also described to interact with R-Smads. 115 The role of Zeb1/2-Smad complexes in EMT has not been studied in detail and it is therefore not clear what the specific roles are for Snail1-Smad3/4 and Zeb1/2-Smad3/4 complexes during EMT. Since Snail1 is more rapidly, but also (pCAF)) by Zeb1, and repressors (C-terminal binding protein (CtBP)) by Zeb2. 115 However, at least for E-cadherin, this model remains controversial since other studies have shown that Zeb1 is a repressor of this gene when induced during TGF-β-driven EMT. 114 The precise contribution of Snail, Zeb1/2 and bHLH factors to the repression of E-cadherin during EMT is not understood but recent data suggest a model of EMT, in which these transcription factors are regulated in a temporally organized fashion. Snail1 expression in normal adult tissues is limited and this factor is generally absent in adult mesenchymal cells. 116 Therefore, it has been proposed that full repression of E-cadherin requires the successive action of Snail1 and Zeb1/Zeb2, perhaps with a more restricted role of Snail2 and E47. 19 Although it has not been demonstrated, the existence of three E-boxes in the E-cadherin promoter enables simultaneous interaction of Snail1 and Zeb proteins with the promoter. Accordingly, reversal of E-cadherin repression may require the elimination of Snail1, Zeb1 and Zeb2. 114 Members of the bHLH family including Twist, E47/TCF3 and TCF4/E2-2 also act as inducers of EMT and transcriptional repressors of E-cadherin. 19, 102, 117 Twist expression is associated with high-grade ductal carcinomas and poor prognosis. 118, 119 While Twist has been shown to bind and repress the E-cadherin promoter in breast epithelial cells 120 it has been suggested that Twist may act through a different mechanism compared to Snail and Zeb proteins, which does not involve direct binding to the E-cadherin promoter. 121 Twist confers metastatic properties to breast tumor cells and stem-like properties in epithelial cells. 6, 7, 117 Twist1 and Twist2 block oncogene-induced senescence by inhibiting p53-and Rb-dependent pathways and act in collaboration with Ras to induce EMT. 122 Furthermore, Twist promotes migration, invasion and resistance to paclitaxel in breast cancer cells via transcriptional activation of AKT2, 123 and can function as a direct repressor of histone acetyltransferase (HAT) activities by direct binding to pCAF and p300. 124 Twist expression is regulated by TGF-β3 and PI3K pathways during palate development 125 and is induced by Fibulin-5 during TGF-β-induced EMT in mammary epithelial cells. 126 Twist is also induced by hypoxia or overexpression of hypoxia inducible factor-1 alpha (Hif-1α) showing a link between the tumor microenvironment and the expression of EMT promoting transcription factors. 127 Twist can also be upregulated by Wnt signaling in mammary epithelial cells.
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KLF8 is another transcription factor with the capacity to bind and repress the E-cadherin promoter and induce EMT. 129 It is currently unknown how KLF8 fits into the scheme and may be affected by other EMT inducers during tumor progression.
Transcriptional activation of mesenchymal genes-role of β-catenin, NFκB, AP-1 and Sp1 transcription factors. The activator protein-1 (AP-1) transcription factor is formed by Jun-Jun homodimers or Jun-Fos/Fra-2 heterodimers and is involved in MMP expression, cancer cell invasion and metastasis. 130 Both Ras/MAPK and Wnt signaling pathways have been reported to activate AP-1 in colon cancer. [131] [132] [133] Inhibition of AP-1 blocks cooperative induction of EMT in human keratinocytes by TGF-β1 and Ras/EGF signaling and conversely, chemical-based system, which plays a key role in cancer invasion and metastasis. 163, 164 PAI-1 is overexpressed at the tumor-stroma interface and is required for the TGF-β/EGF-induced invasive phenotype in human cutaneous squamous cell carcinoma. 165 The expression of PAI-1 in cervical cancer strongly correlates with tumor cell invasion, lymph node metastasis and poor prognosis.
166 Sp1-Smad3 complexes also induce the expression of the TGF-β receptor endoglin, 167 the type alpha2 (I) collagen 168 and the type VII collagen 169 in response to TGF-β. Finally, Smad proteins can interact with other cofactors to induce EMT activators. It has been found that HMGA2, a nonhistone chromatin modifier, regulates Snail1 expression through interaction with Smads. 88 HMGA2 is required for TGF-β induced EMT in NMuMG cells 87 and maintains oncogenic Rasinduced EMT in human pancreatic cells. 86 Smad also interacts with the classical chromatin modulators p300, histone deacetylase (HDAC) and pCAF displaying the additional regulation control of Smad binding complexes.
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Perspectives
EMT in tumors-when and where? In this review we have highlighted data showing evidence of transcriptional crosstalk between TGF-β, Wnt and Ras pathways in EMT and tumor cell invasion. We have discussed how these signaling pathways cooperate to activate EMT promoting transcription factors and complexes. But, how is EMT induced in tumors? In vivo evidence of EMT in tumors has been difficult to obtain likely due to the transient nature of the EMT process and the difficulty in capturing the process in snapshot images of fixed tumor tissue. In our studies, combined immunohistochemical staining of positive (Snail/Zeb/Twist) and negative (E-cadherin/CAR/occludin) EMT markers and Smad3/4 proved to be an efficient approach to identify EMT cells in samples of invasive human ductal breast carcinomas (Fig. 3) . 60 Loss of E-cadherin/CAR at intercellular junctions significantly correlated with nuclear expression of Snail1 and Smad3/4 at invasive regions supporting a role for Snail-Smad3/4 complexes in the repression of junction proteins during breast cancer cell invasion. Future studies using similar staining approaches may be successful in identifying EMT cells in the tumor microenvironment and helpful in determining when and where EMT is induced in tumors. Based on data reviewed here the induction of EMT would be the consequence transiently, induced upon TGF-β stimulation compared to Zeb1/2 it is possible that Snail1-Smad3/4 complexes facilitate recruitment of Zeb1/2 to CAR, occludin and E-cadherin promoters. This idea would fit with the limited expression of Snail1, 116 and more ubiquitous expression of Zeb1, 151, 152 in mesenchymal cells within adult tissues. Another scenario is that Snail1 and Zeb1/2 prefer different E-boxes within gene promoters suggesting that they could interact and regulate these gene promoters simultaneously.
EMT promoting Smad activator complexes. Smad proteins can also form complexes with downstream effectors of Wnt and Ras pathways. For instance, β-catenin-Smad2 complexes are rapidly formed during TGF-β-induced EMT in alveolar epithelial cells and promote transcriptional activation of mesenchymal genes like α-SMA and PAI-1. 153 The formation of β-cateninSmad2 complexes is dependent on α3β1 integrin mediated phosphorylation of β-catenin, which releases β-catenin from its interaction with E-cadherin. A pathophysiological relevance of these findings is inferred by the presence of β-catenin-Smad2 complexes in myofibroblasts in lung tissues from patients with idiopathic pulmonary fibrosis. In support of this, decreased fibrosis and accumulation of myofibroblasts is seen in α3 deficient mice when exposed to bleomycin. 154 β-catenin-Smad3/4 complexes stabilize β-catenin and assist in its nuclear translocation and transcriptional activity in chondrocytes. 155 A role for these complexes in tumor cells is suggested by data showing that silencing of Smad4 in pancreatic carcinoma cells leads to decreased β-catenin levels and signaling activity. Smad3-AP-1 and Smad3-Sp1/Sp3 complexes regulate the expression of vimentin in myogenic cells in response to TGF-β1. 160 AP-1-dependent promoters are synergistically activated by Smad3 and Jun proteins. 161 Sp1-Smad3 complexes activate the plasminogen activator inhibitor-1 (PAI-1) promoter in response to TGF-β. 162 PAI-1 is a member of the plasminogen activation 
Identification of Novel EMT Promoting Complexes
In addition to Snail, Zeb, Twist, AP-1 and β-catenin transcription factors a number of other EMT associated transcription factors have been shown to interact with Smads (Fig.  4) . Future studies will determine to what extent these factors form Smad complexes that drive EMT and tumor cell invasion.
Methodological advances like Chip-Chip techniques will be useful in identifying the specific contribution of transcription factors/complexes for the regulation of target genes during EMT. Technical improvements allowing specific gene expression profiling of invading tumor cells will help to identify novel EMT promoting transcriptional complexes. In this area, Condeelis and coworkers have been successful in developing intravital imaging techniques that have allowed the identification of novel regulatory mediators of invasion including cytoskeletal proteins, such as cofilin and Mena. [177] [178] [179] Intravital imaging has also been shown to be a powerful method to study the role of cohesive versus TGF-β mediated single cell migration during breast cancer metastasis. 83 Furthermore, genome-wide transcriptional profiling approaches have been used to identify specific gene expression signatures involved in the invasive properties of breast cancer cell lines. 180, 181 Dissection of the molecular machinery involved in promoting EMT during tumor cell invasion may lead to the development of novel treatment strategies for invasive and metastatic cancer.
of simultaneous activation of some of the EMT promoting pathways described above.
The inflammatory tumor microenvironment. Although inflammation has been associated with cancer for a long time it is not until recently inflammation has been linked to EMT and tumor cell invasion. [171] [172] [173] Immune cells like macrophages and T lymphocytes infiltrating the tumor stroma may contribute to EMT by secreting TGF-β and other inflammatory cytokines as well as proteases and growth factors. Macrophages have been shown activate Wnt signaling in gastric tumor cells via secretion of TNFα. 174 Thus, in combination with intrinsic mutagenic events, such as activation of oncogenic Ras, a hallmark of many tumor cells, the inflammatory milieu at the tumor-stroma interface may provide a fundament for simultaneous activation of Ras, TGF-β and Wnt signaling pathways and the induction of EMT. Inflammatory breast cancer, a rare but particularly aggressive form of breast cancer, displays EMT properties, which supports inflammation as a promoting factor for EMT and tumor cell invasion. Further dissection of how inflammatory signals promote EMT is needed and may lead to important discoveries and new therapies.
Stem cell niches. The idea that tumors may originate from stem cells was suggested already in the 19 th century and has recently gained much attention due to the identification of cancer stem/initiating cells in tumors. 175 Wnt signaling plays an important and perhaps universal role in the maintenance and selfrenewal of stem cell/progenitor cell niches. 176 If such progenitor 
